Growth Hormone Signaling
Studied for its stimulation of endogenous growth hormone secretion via the GHRH receptor.
Overview
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), extending the native 44-amino acid sequence with a stabilizing hexenoyl modification at the N-terminus. This structural change confers resistance to enzymatic degradation, making it a durable tool for studying growth hormone secretion and downstream metabolic pathways.
Suria's Tesamorelin is synthesized to high purity and independently verified prior to release, supporting reliable research into IGF-1 modulation, lipid metabolism, and body-composition signaling.
Research Use Only. Not for human or veterinary use.
Specifications
Third-Party Testing
Available third-party analytical documentation for Tesamorelin can be reviewed for applicable batches through Suria's Batch Documentation system. We believe documentation should be held to the same standard as the research it supports.
Certificates of Analysis will be available at time of launch.
Research Highlights
Studied for its stimulation of endogenous growth hormone secretion via the GHRH receptor.
A frequent focus of visceral fat and lean-mass research models.
Engineered with an N-terminal modification that resists rapid enzymatic breakdown.
One of the most extensively studied GHRH analogs in metabolic research.
Storage
Store as specified above, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the recommended window for your protocol.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation